In the world of wellness science, few molecules attract as much attention as NAD⁺ — nicotinamide adenine dinucleotide. Despite its rather imposing name, this compound is neither exotic nor new: it has been present in every cell of every living organism since life began, quietly orchestrating the reactions that keep us energised, resilient, and well. What has changed is our understanding of just how central it is, and what its decline over time may mean for how we age.
What Is NAD⁺?
NAD⁺ is a coenzyme — a helper molecule that works in partnership with enzymes to drive essential chemical reactions. Discovered over a century ago, it was initially recognised for its role in energy metabolism. Scientists have since established that its responsibilities extend far beyond that, touching almost every major system in the body.
Its primary function is to act as an electron carrier: it shuttles electrons between molecules during the metabolic processes that convert food into ATP (adenosine triphosphate), the body’s principal energy currency. In doing so, NAD⁺ cycles continuously between two forms — its oxidised state (NAD⁺) and its reduced state (NADH) — making it indispensable to the very mechanics of cellular life.
Why Does It Matter?
NAD⁺ is perhaps best understood not as a single-purpose molecule, but as a master facilitator — one whose influence extends across energy production, genetic integrity, inflammation control, and brain health.
Within the mitochondria, the tiny organelles often described as the cell’s power plants, NAD⁺ is an essential participant in the reactions that generate ATP. Without sufficient NAD⁺, this process falters, and the resulting energy deficit is felt throughout the body as fatigue and reduced physical capacity.
NAD⁺ is also fundamental to DNA repair. Each day, genetic material sustains damage from sunlight, environmental pollutants, and the normal by-products of metabolism. A class of enzymes known as PARPs — poly-ADP ribose polymerases — depend on NAD⁺ to carry out these repairs efficiently. When NAD⁺ levels are low, the repair process becomes less reliable, and the cumulative effect over time may contribute to accelerated cellular ageing.
Perhaps most intriguingly, NAD⁺ is required for the activation of sirtuins — proteins sometimes referred to as the body’s longevity regulators. Sirtuins govern a broad range of protective functions, including the suppression of inflammation, the regulation of metabolism, and the maintenance of cellular stability under stress. They cannot perform this work without NAD⁺ as their fuel. Finally, the brain — the body’s most energy-intensive organ — depends heavily on NAD⁺ not only for its considerable energy demands, but also for neuronal repair and the quality of cognitive function over time.
The Link Between Vitamin B3 and NAD⁺
The body does not store NAD⁺ in large quantities; it must continuously synthesise it from available raw materials. The most direct of these are the various forms of vitamin B3, also known as niacin. Vitamin B3 exists in several related forms: nicotinic acid and nicotinamide are the most familiar, found widely in food and standard supplements. Two newer forms — nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — have attracted particular scientific interest for their apparent efficiency as NAD⁺ precursors, meaning the body can convert them into NAD⁺ more readily than older forms.
The relationship is straightforward: vitamin B3 in its various forms is the raw material, and NAD⁺ is the finished product. This is why severe deficiency of vitamin B3, historically known as pellagra, produces such wide-ranging symptoms — fatigue, cognitive changes, and skin deterioration — all of which reflect the consequences of impaired NAD⁺ production. The body can also produce NAD⁺ from tryptophan, an amino acid found in eggs, dairy, poultry, and nuts, which is why a varied, protein-rich diet contributes to maintaining adequate levels.
The Natural Decline of NAD⁺ with Age
Research consistently shows that NAD⁺ levels decline significantly with age — in some studies, by more than half between young adulthood and midlife. This reduction is thought to occur for several reasons: the enzymes that consume NAD⁺ become more active over time, dietary intake of precursors may diminish, and the body’s own synthesis efficiency decreases. The consequences are not merely theoretical. Lower NAD⁺ is associated with reduced energy, slower recovery from physical exertion, impaired DNA repair, and greater susceptibility to the metabolic and inflammatory changes that characterise ageing. Supporting NAD⁺ levels has therefore become a genuine focus of longevity medicine.
How to Support NAD⁺

There is encouraging evidence that NAD⁺ levels can be meaningfully influenced through lifestyle, nutrition, targeted supplementation, and, where clinically appropriate, intravenous therapy. These approaches are not mutually exclusive; the most effective strategy typically combines several.
Nutrition
A diet rich in vitamin B3 provides the body with the precursors it requires to synthesise NAD⁺. Good dietary sources include poultry, oily fish such as tuna and salmon, legumes, whole grains, and mushrooms — particularly portobello and shiitake varieties. Adequate protein intake also matters, since tryptophan, an amino acid present in eggs, dairy, and nuts, offers an additional biosynthetic route to NAD⁺. Conversely, excessive alcohol consumption actively depletes NAD⁺, as the body diverts it to process ethanol — a reason to favour moderation.
Exercise and Sleep
Physical activity is one of the most reliable natural stimuli for NAD⁺ metabolism. Aerobic exercise — brisk walking, cycling, or swimming — enhances mitochondrial function and encourages the recycling of NADH back into NAD⁺. Resistance training similarly increases cellular energy demand, which stimulates NAD⁺ pathways and supports the formation of new mitochondria, a process known as mitochondrial biogenesis. Even consistent, moderate activity of around 20 to 30 minutes daily produces measurable metabolic benefits.
Sleep is equally important. NAD⁺ levels fluctuate in accordance with the body’s circadian rhythm — its internal 24-hour clock — and disrupted or insufficient sleep interferes with the NAD⁺-dependent proteins that govern repair and energy balance overnight. Aiming for seven to nine hours of consistent, good-quality sleep, and maintaining a regular sleep-wake schedule, supports the natural rhythm of NAD⁺ activity.
Oral Supplements: NMN and NR
Oral NAD⁺ supplements — products that contain the molecule directly — are widely available but offer limited practical benefit. NAD⁺ itself is broken down in the digestive tract before it can reach the bloodstream in meaningful quantities, and current evidence suggests it does not reliably raise cellular levels when taken by mouth.
Its precursors are a different matter. Nicotinamide mononucleotide (NMN), typically taken at doses of 250 to 600 mg per day, is converted into NAD⁺ inside cells and has shown promising results in both animal studies and early human trials, with reported improvements in metabolic function and vascular health. Nicotinamide riboside (NR), usually taken at 250 to 500 mg per day, has been demonstrated in multiple human studies to safely and consistently raise NAD⁺ levels in the blood and tissues. Both are generally well tolerated. As with any supplement, they are best used under professional guidance rather than independently.
Intravenous NAD⁺ Therapy
For individuals seeking a more direct and immediate means of replenishing NAD⁺, intravenous (IV) infusion offers a compelling option. By delivering NAD⁺ directly into the bloodstream, this approach bypasses the digestive limitations that reduce the effectiveness of oral supplementation, achieving far higher concentrations in the tissues with considerably greater speed.
How the Infusion Is Prepared
Clinically, NAD⁺ for infusion is available in three principal preparations. Fresh frozen NAD⁺ is considered the most potent: the solution is frozen immediately after preparation to preserve stability, then thawed and used promptly, as the molecule is sensitive to light and heat. Lyophilised, or freeze-dried, powder offers greater shelf stability — it is reconstituted with sterile saline immediately before infusion and is widely used in clinical settings. Liquid solutions stored in vials are more convenient to handle but less stable over time; their potency may diminish if exposure to temperature variation or light is not carefully managed. Many clinics prefer frozen or lyophilised preparations for consistency and reliability of results.
What to Expect During a Session
NAD⁺ is diluted in sterile saline and administered slowly through an intravenous line, typically into a vein in the forearm. Sessions generally last between one and a half and three hours, depending on the dose and individual tolerance. Faster infusion rates are associated with greater discomfort, so the drip is always titrated carefully. Most patients find the process straightforward; they rest, read, or simply relax while the infusion runs. Common dosages range from 250 to 750 mg per session, though some protocols use higher amounts for specific clinical purposes.
Initial treatment programmes often involve a ‘loading phase’ of more frequent sessions — typically daily or on alternate days for four to ten days — followed by maintenance infusions every four to eight weeks, depending on the individual’s goals and clinical response.
Reported Benefits and Current Evidence
Many individuals report improvements in energy, mental clarity, mood, and physical recovery following IV NAD⁺ therapy, often within the first few sessions. The biological rationale is well established: raising NAD⁺ levels directly supports the mitochondrial and repair functions described earlier in this article. Clinical research in this specific area is still developing, and the most robust evidence relates to the broader role of NAD⁺ in cellular metabolism rather than IV therapy in isolation. A 2019 pilot study suggested potential benefits in substance use recovery; larger controlled trials are ongoing. The existing data are encouraging, and the underlying science is sound, though patients should approach any specific anti-ageing claims with appropriate realism.
Safety and Contraindications
IV NAD⁺ is generally well tolerated when administered by qualified professionals in a clinical setting, but it is not without considerations. During the infusion, some individuals experience transient sensations such as chest tightness, abdominal discomfort, nausea, flushing, or a mild increase in heart rate. These effects are typically related to infusion speed and resolve promptly when the drip rate is reduced. After the session, mild fatigue or a brief headache may occasionally occur, and there may be minor local irritation at the IV site.
IV NAD⁺ should be avoided or used only under specialist supervision in individuals with significant heart disease, liver failure, or chronic kidney disease. It is not recommended during pregnancy or whilst breastfeeding, as safety data in these groups are insufficient. A thorough consultation and medical assessment before commencing treatment is essential.
NAD⁺ Support at a Glance
| Method | How It Helps | Practical Guidance |
| Balanced diet | Provides B3 and tryptophan as NAD⁺ precursors | Include poultry, oily fish, legumes, and mushrooms daily |
| Regular exercise | Stimulates NAD⁺ recycling and mitochondrial health | Aim for 30 minutes of moderate activity most days |
| Quality sleep | Supports circadian NAD⁺ fluctuation and overnight repair | Maintain consistent sleep and wake times; avoid screens before bed |
| Alcohol moderation | Prevents NAD⁺ depletion through metabolic diversion | Limit alcohol to occasional, moderate consumption |
| NR or NMN supplements | May raise NAD⁺ levels more effectively than oral NAD⁺ | 250–600 mg daily; use under professional guidance |
| IV NAD⁺ infusion | Delivers NAD⁺ directly to tissues at therapeutic concentrations | 250–750 mg per session; performed in a clinical setting |
Dosage Reference
| Form | Typical Range | Notes |
| Vitamin B3 (niacin) | 14–16 mg/day (dietary reference intake); up to 1,000 mg/day therapeutic | High therapeutic doses require medical supervision |
| Nicotinamide riboside (NR) | 250–500 mg/day | Demonstrated to raise NAD⁺ levels in human studies |
| Nicotinamide mononucleotide (NMN) | 250–600 mg/day | Well tolerated; promising evidence in metabolic health |
| IV NAD⁺ infusion | 250–750 mg per session (up to 1,500 mg in some protocols) | Infused over 1.5–3 hours; frequency tailored individually |
Frequently Asked Questions
How does IV NAD⁺ differ from taking oral supplements?
Oral NAD⁺ is broken down in the digestive system before it can reach the cells, making it largely ineffective when taken by mouth. Precursors such as NMN and NR are better absorbed and do raise cellular NAD⁺ levels, but intravenous delivery achieves considerably higher concentrations more rapidly, as the molecule enters the bloodstream directly. The two approaches are not mutually exclusive — many individuals combine ongoing oral supplementation with periodic IV infusions.
How soon will I notice a difference after an IV infusion?
Responses vary between individuals. Some report improvements in energy, focus, or mood within the first one or two sessions; others notice more gradual changes over several weeks, particularly when infusions are combined with supportive lifestyle habits. An initial loading course tends to produce the most noticeable early effects.
How often should I have IV NAD⁺ infusions?
There is no single schedule that suits everyone. Many programmes begin with a loading phase of daily or alternate-day infusions over four to ten days, transitioning to maintenance sessions every four to eight weeks thereafter. A clinician will assess your individual circumstances — health goals, baseline NAD⁺ status, and response to treatment — and recommend a frequency accordingly.
Are there any side effects I should be aware of?
During the infusion, transient sensations such as chest tightness, mild nausea, flushing, or a slight increase in heart rate may occur if the drip runs too quickly. Slowing the infusion rate typically resolves these promptly. Afterwards, mild fatigue or a brief headache is occasionally reported but generally passes within a day. Serious adverse effects are rare when the procedure is carried out by trained professionals in an appropriate clinical environment.
Is IV NAD⁺ suitable for everyone?
It is not appropriate for all individuals. Those with significant heart disease, liver failure, or chronic kidney disease should avoid it or seek specialist input first. It is also contraindicated during pregnancy and whilst breastfeeding. A thorough consultation and medical assessment are always conducted before any treatment is commenced.
Can I support my NAD⁺ levels without supplements or infusions?
Yes, to a meaningful degree. A varied diet rich in vitamin B3, regular physical activity, good sleep hygiene, and moderation in alcohol all support healthy NAD⁺ metabolism. For individuals in good general health and without significant deficiency, lifestyle measures alone may be sufficient. Supplements and IV therapy are most relevant where a more targeted or rapid response is sought, or where age-related decline has become clinically significant.
How long do the effects of an IV infusion last?
The duration of benefit varies depending on the individual’s baseline levels, the dose administered, and their broader lifestyle. Many people report sustained improvements for several weeks following a course of infusions. Maintenance sessions help to preserve these gains over time, particularly as NAD⁺ naturally declines with age.
In Summary
NAD⁺ is not a wellness trend — it is a biological cornerstone, one whose influence on energy, resilience, and cellular repair becomes increasingly relevant as we age. The science supporting its role is well established; the evidence for therapeutic approaches to replenishing it continues to grow. Whether through considered dietary choices, targeted supplementation, or intravenous infusion under clinical supervision, supporting NAD⁺ levels represents one of the more evidence-informed strategies available in modern preventive medicine.
As with all aspects of personalised health, the most effective approach is one tailored to the individual. A consultation with a qualified clinician ensures that any programme — whether lifestyle-based, supplementary, or infusion-led — is matched to your specific needs, health history, and goals.
References
Verdin E. NAD⁺ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208–1213.
Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD⁺-boosting molecules: the in vivo evidence. Cell Metabolism. 2018;27(3):529–547.
Fang EF, Lautrup S, Hou Y, et al. NAD⁺ in aging: molecular mechanisms and translational implications. Trends in Molecular Medicine. 2017;23(10):899–916.
Yoshino J, Baur JA, Imai SI. NAD⁺ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metabolism. 2018;27(3):513–528.
Kirkland JB, Meyer-Ficca ML. Niacin. Advances in Nutrition. 2018;9(1):16–22.
Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in healthy humans. Nature Communications. 2016;7:12948.
Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD⁺ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports. 2019;28(7):1717–1728.
Braidy N, Berg J, Bhattacharya A, et al. Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases. Antioxidants & Redox Signaling. 2019;30(2):251–294.
Lautrup S, Sinclair DA, Mattson MP, Fang EF. NAD⁺ in brain aging and neurodegenerative disorders. Cell Metabolism. 2019;30(4):630–655.